Clarient launches non-small cell lung cancer diagnostic
This article was originally published in Clinica
Executive Summary
Clarient has launched its Insight Dx Pulmonary test to help classify non-small cell lung cancer (NSCLC) patients. It is now available as a lab-developed test under CLIA-regulations.